Below are the most recent publications written about "Drug Resistance, Microbial" by people in Profiles.
-
Ben Maamar S, Glawe AJ, Brown TK, Hellgeth N, Hu J, Wang JP, Huttenhower C, Hartmann EM. Mobilizable antibiotic resistance genes are present in dust microbial communities. PLoS Pathog. 2020 01; 16(1):e1008211.
-
Knight GM, Davies NG, Colijn C, Coll F, Donker T, Gifford DR, Glover RE, Jit M, Klemm E, Lehtinen S, Lindsay JA, Lipsitch M, Llewelyn MJ, Mateus ALP, Robotham JV, Sharland M, Stekel D, Yakob L, Atkins KE. Mathematical modelling for antibiotic resistance control policy: do we know enough? BMC Infect Dis. 2019 Nov 29; 19(1):1011.
-
Van Katwyk SR, Balasegaram M, Boriello P, Farrar J, Giubilini A, Harrison M, Kieny MP, Kirchhelle C, Liu J, Outterson K, Pate MA, Poirier M, Røttingen JA, Savulescu J, Sugden R, Thamlikitkul V, Weldon I, Davies S, Hoffman SJ. A roadmap for sustainably governing the global antimicrobial commons. Lancet. 2019 11 16; 394(10211):1788-1789.
-
Libby EA, Reuveni S, Dworkin J. Multisite phosphorylation drives phenotypic variation in (p)ppGpp synthetase-dependent antibiotic tolerance. Nat Commun. 2019 11 13; 10(1):5133.
-
Hicks AL, Kissler SM, Lipsitch M, Grad YH. Surveillance to maintain the sensitivity of genotype-based antibiotic resistance diagnostics. PLoS Biol. 2019 11; 17(11):e3000547.
-
O'Neal F, Kramer J, Cooper M, Septimus E, Sharma S, Burgess LH. Analysis of antibiotic use in a large network of emergency departments. Am J Health Syst Pharm. 2019 10 15; 76(21):1753-1761.
-
Pensar J, Puranen S, Arnold B, MacAlasdair N, Kuronen J, Tonkin-Hill G, Pesonen M, Xu Y, Sipola A, Sánchez-Busó L, Lees JA, Chewapreecha C, Bentley SD, Harris SR, Parkhill J, Croucher NJ, Corander J. Genome-wide epistasis and co-selection study using mutual information. Nucleic Acids Res. 2019 10 10; 47(18):e112.
-
Sutherland T, Mpirimbanyi C, Nziyomaze E, Niyomugabo JP, Niyonsenga Z, Muvunyi CM, Mueller A, Bebell LM, Nkubana T, Musoni E, Talmor D, Rickard J, Riviello ED. Widespread antimicrobial resistance among bacterial infections in a Rwandan referral hospital. PLoS One. 2019; 14(8):e0221121.
-
Johnson EO, LaVerriere E, Office E, Stanley M, Meyer E, Kawate T, Gomez JE, Audette RE, Bandyopadhyay N, Betancourt N, Delano K, Da Silva I, Davis J, Gallo C, Gardner M, Golas AJ, Guinn KM, Kennedy S, Korn R, McConnell JA, Moss CE, Murphy KC, Nietupski RM, Papavinasasundaram KG, Pinkham JT, Pino PA, Proulx MK, Ruecker N, Song N, Thompson M, Trujillo C, Wakabayashi S, Wallach JB, Watson C, Ioerger TR, Lander ES, Hubbard BK, Serrano-Wu MH, Ehrt S, Fitzgerald M, Rubin EJ, Sassetti CM, Schnappinger D, Hung DT. Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes. Nature. 2019 07; 571(7763):72-78.
-
Rogers Van Katwyk S, Grimshaw JM, Nkangu M, Nagi R, Mendelson M, Taljaard M, Hoffman SJ. Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map. PLoS Med. 2019 06; 16(6):e1002819.